Affiliation:
1. Department of Chemistry, University of Fort Hare, Alice 5700, South Africa
Abstract
Cancer is ranked among lethal diseases globally, and the increasing number of cancer cases and deaths results from limited access to effective therapeutics. The use of plant-based medicine has been gaining interest from several researchers. Carvacrol and its isomeric compound, thymol, are plant-based extracts that possess several biological activities, such as antimalarial, anticancer, antifungal, and antibacterial. However, their efficacy is compromised by their poor bioavailability. Thus, medicinal scientists have explored the synthesis of hybrid compounds containing their pharmacophores to enhance their therapeutic efficacy and improve their bioavailability. Hence, this review is a comprehensive report on hybrid compounds containing carvacrol and its isomer, thymol, with potent anticancer and antibacterial agents reported between 2020 and 2024. Furthermore, their structural activity relationship (SAR) and recommended future strategies to further enhance their therapeutic effects will be discussed.
Funder
University of Fort Hare, Sasol Foundation, South African Medical Research Foundation, National Research Foundation, and Govan Mbeki Research and Development Center
Reference72 articles.
1. Synthesis and evaluation of antiproliferative and mPGES-1 inhibitory activities of novel carvacrol-triazole conjugates;Demirbolat;Org. Commun.,2022
2. Zielińska-Błajet, M., Pietrusiak, P., and Feder-Kubis, J. (2021). Selected monocyclic monoterpenes and their derivatives as effective anticancer therapeutic agents. Int. J. Mol. Sci., 22.
3. Estimated global cancer incidence in the oldest adults in 2018 and projections to 2050;Pilleron;Int. J. Cancer.,2021
4. Bansal, A., Saleh-E-In, M.M., Kar, P., Roy, A., and Sharma, N.R. (2022). Synthesis of Carvacrol Derivatives as Potential New Anticancer Agent against Lung Cancer. Molecules, 27.
5. Shabani, H., Karami, M.H., Kolour, J., Sayyahi, Z., Parvin, M.A., Soghala, S., Baghini, S.S., Mardasi, M., Chopani, A., and Moulavi, P. (2023). Anticancer activity of thymoquinone against breast cancer cells: Mechanisms of action and delivery approaches. Biomed. Pharmacother., 165.